MARY GRIZZARD: Open Payments
NPI 1821509266 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$40,084 in 115 payments from 24 companies in 2025. Trend: 2023 $8,239 · 2024 $13,057 · 2025 $40,084
Speaker / faculty: $20,725Travel & lodging: $11,553Consulting: $5,540Food & beverage: $2,266
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 64 | $38,772 |
| Regeneron Healthcare Solutions, Inc. | 5 | $177 |
| SOBI, INC | 2 | $145 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| Celgene Corporation | 5 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $103 |
| Daiichi Sankyo Inc. | 4 | $102 |
| Janssen Biotech, Inc. | 4 | $83 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| GENZYME CORPORATION | 3 | $51 |
Products named: LORBRENA, VIZIMPRO, BRAFTOVI, LIBTAYO, Vonjo, REBLOZYL, Enhertu, KISQALI.
Industry payments across TN — which companies pay providers there.
